Linda S. Lindström

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

Linda S. Lindström, Eva Karlsson, Ulla Wilking et al. · Journal of Clinical Oncology · 2012 · 517 citations

Hormonal Receptors, Breast Oncology, Progesterone Receptor +15

Automatic assessment of electromyogram quality

Christer A. Sinderby, Linda S. Lindström, A. Grassino · Journal of Applied Physiology · 1995 · 143 citations

Automatic Assessment, Engineering, Measurement +20

Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades

Laura J. Esserman, Christina Yau, Carlie K. Thompson et al. · JAMA Oncology · 2017 · 129 citations · Full text

Long-term outcome in young women with breast cancer: a population-based study

Hanna Fredholm, Kristina Magnusson, Linda S. Lindström et al. · Breast Cancer Research and Treatment · 2016 · 126 citations · Full text

HER2 status in a population-derived breast cancer cohort: discordances during tumor progression

Ulla Wilking, Eva Karlsson, Lambert Skoog et al. · Breast Cancer Research and Treatment · 2010 · 118 citations · Full text

Her2 Status, Breast Oncology, Cancer Epidemiology +7